Esterified Pectin TLR2 Binding for Inflammatory Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing and treating inflammatory diseases, such as arthritis and gastrointestinal disturbances in humans and animals, often rely on costly and invasive surgical procedures or medications with undesirable side effects, and there is a need for alternative approaches that avoid these issues.
Innovation Solution
The use of esterified pectins with a degree of esterification (DE) of less than 65% is effective in preventing, reducing, or treating inflammatory disorders by binding Toll-like receptor 2 (TLR2), thereby regulating intestinal barrier function and immune responses, and can be incorporated into food or feed compositions at lower concentrations for improved formulation and efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional surgical procedures or medications are used to treat inflammatory diseases, then treatment effectiveness is achieved, but side effects and invasiveness increase
Solution Approach 1:
The patent uses food-grade pectin, a natural, biodegradable polysaccharide, as a temporary, non-invasive intervention to modulate immune responses. The pectin acts as a short-term dietary supplement that provides therapeutic benefit without the long-term side effects of conventional medications, aligning with the principle of using simple, disposable-like solutions for temporary therapeutic needs.
Solution Approach 2:
The pectin serves as an intermediary substance that mediates between the diet and the immune system. It binds to TLR2 receptors on immune cells, acting as a bridge that modulates immune responses without directly attacking pathogens or causing the side effects associated with conventional anti-inflammatory drugs. This intermediary approach allows for treatment effectiveness while avoiding harmful side effects.
2Reliability
If high concentrations of pectin are used in food compositions, then anti-inflammatory efficacy is improved, but formulation complexity and cost increase
Solution Approach 1:
The patent specifies a particular degree of esterification range (20-60%) for the pectin to optimize its anti-inflammatory activity. By controlling this chemical parameter, the patent achieves high efficacy at lower concentrations, reducing formulation complexity. The defined parameter range allows for standardized production and simplifies the formulation process while maintaining therapeutic effectiveness.
3Measurement precision
If specific degree of esterification is required for pectin efficacy, then treatment precision is improved, but manufacturing complexity increases
Solution Approach 1:
The patent defines a specific degree of esterification range (20-60%) that can be achieved through conventional pectin extraction and processing methods. This parameter specification balances treatment precision with manufacturing feasibility, as the range accommodates variations in natural pectin sources while ensuring therapeutic efficacy. The specified range allows manufacturers to work with naturally varying pectin materials without requiring overly complex processing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Esterified pectins with a DE of less than 65% effectively reduce inflammatory responses and improve overall health and welfare in humans and animals by binding TLR2, offering a non-invasive and side-effect-free treatment option for inflammatory diseases, as demonstrated by their ability to inhibit NFκB activation and improve gastrointestinal health.
Implementation Method 1
esterified pectins with a degree of esterification (DE) of less than 65% is effective in preventing, reducing, or treating inflammatory disorders by binding Toll-like receptor 2 (TLR2)
Implementation Method 2
demonstrated by their ability to inhibit NFκB activation and improve gastrointestinal health
Data Source
AI summary
This invention relates generally to compositions and methods for combating inflammatory disease and particularly to the use of food and/or feed compositions for preventing, reducing and/or treating inflammatory disorders, diseases, or discomforts, wherein the compositions comprising at least one specific pectin.